Prostate cancer: assessment of risk using digital rectal examination, tumor grade, prostate-specific antigen, and systematic biopsy (Q33832159)

29 July 2017

1 reference

title

Prostate cancer: assessment of risk using digital rectal examination, tumor grade, prostate-specific antigen, and systematic biopsy (English)

1 reference

29 July 2017

0 references

1 reference

Presti JC Jr

1

1 reference

29 July 2017

publication date

1 January 2000

1 reference

Radiologic Clinics of North America

29 July 2017

published in

1 reference

29 July 2017

volume

38

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

49-58

1 reference

Sonographic and pathological staging of patients with clinically localized prostate cancer

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

Systematic sextant biopsies in the prediction of extracapsular extension at radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

The Inability of Prostate Specific Antigen Index to Enhance the Predictive Value of Prostate Specific Antigen in the Diagnosis of Prostatic Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

Prospective evaluation of systematic sextant transition zone biopsies in large prostates for cancer detection

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

Cell proliferation in carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

Combined modality staging of prostate carcinoma and its utility in predicting pathologic stage and postoperative prostate specific antigen failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

Core cancer length in ultrasound-guided systematic sextant biopsies: a preoperative evaluation of prostate cancer volume

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

Estimation of prostate cancer volume by multiple core biopsies before radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

The use of percent free prostate specific antigen for staging clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

The role of free/total prostate-specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

The Use of Prostate Specific Antigen, Clinical Stage and Gleason Score to Predict Pathological Stage in Men with Localized Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

Impact of Radical Prostatectomy in the Management of Clinically Localized Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

Comparing clinical staging plus transrectal ultrasound with surgical-pathologic staging of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of carcinoma of the prostate: ethnic variations

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

Positive fraction of systematic biopsies predicts risk of relapse after radical prostatectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after radical prostatectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

Comparison of prostate specific antigen with prostate specific antigen density for 3 clinical applications.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

Hormone therapy in prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

Long-Term (15 Years) Results After Radical Prostatectomy For Clinically Localized (Stage T2c Or Lower) Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970149-4

7 January 2021

10.1016/S0033-8389(05)70149-4

Identifiers

DOI

1 reference

29 July 2017

1 reference